Related Experiment Videos
New therapeutic approaches to cognitive impairment
1Department of Psychiatry and the Behavioral Sciences, School of Medicine, University of Southern California, Los Angeles 90033, USA.
The Journal of Clinical Psychiatry
|September 10, 1998
Summary
Cholinesterase inhibitors show promise for improving dementia cognitive symptoms. Research also explores antioxidants and other drugs to slow cognitive decline and manage behavioral issues in dementia patients.
Area of Science:
- Neurology
- Pharmacology
Background:
- Cognitive impairment is a core feature of dementia.
- Current treatments for dementia primarily focus on symptomatic relief.
Purpose of the Study:
- To review current and emerging pharmacologic therapies for cognitive impairment in dementia.
- To discuss the role of cholinesterase inhibitors and other agents in managing dementia symptoms.
Main Methods:
- Review of clinical pharmacologic approaches for dementia.
- Emphasis on cholinergic strategies and cholinesterase inhibitors.
- Discussion of research into antioxidants and monoamine oxidase-B inhibitors.
Main Results:
- Cholinesterase inhibitors are a promising pharmacologic approach for cognitive symptoms.
- Antioxidants and other agents are under investigation for slowing cognitive decline.
- Pharmacologic interventions may also impact behavioral symptoms and different dementia types.
Conclusions:
- Cholinesterase inhibitors are nearing clinical availability and offer a promising avenue for dementia treatment.
- Further research into dosing, side effects, and mechanisms will optimize drug efficacy.
- Combined pharmacologic and psychosocial interventions may improve patient outcomes and delay institutionalization.